Ulcerative Colitis

New Strategies to Improve the Quality of Inflammatory Bowel Disease (IBD) Care

Jan. 19, 2018

Innovative IBD research to be presented at the Crohn’s & Colitis Congress™

Beyond Drugs for IBD: Improving the Overall Health of IBD Patients

Jan. 19, 2018

Actionable IBD research to be presented at the Crohn’s & Colitis Congress™

New Drugs for Inflammatory Bowel Disease (IBD)

Jan. 19, 2018

Breakthrough IBD research to be presented at the Crohn’s & Colitis Congress™

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.
Advertisement

How Will Translational Advances in Pediatric IBD Affect Practices?

Oct. 17, 2017

Dr. Rosen will discuss how new findings can make a difference for pediatric IBD patients at the Crohn’s & Colitis Congress.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

GIs Should be Able to Prescribe the Most Beneficial Treatments

Oct. 4, 2017

AGA supports Restoring the Patient’s Voice Act — new legislation that facilitates treatment appeals to insurance companies.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Crohn’s & Colitis Congress Offers Reporters Access to Leading IBD Research

Sept. 20, 2017

Implementing AGA’s Newest IBD Guideline in Your Practice

Sept. 18, 2017

Experts will provide guidance around the latest IBD guidelines at the 2018 Crohn’s & Colitis Congress.™

Share Your Cutting-Edge IBD Research

Sept. 11, 2017

The processing fee for oral and/or poster presentation is being waived. Submissions are due by October 31 at 9 p.m. ET.

Blog: Do Fatty Acids Increase Risk of Ulcerative Colitis Flares?

Sept. 6, 2017

Palm oil, coconut oil and dairy fats may increase flares according to prospective study of 412 patients. Read more on the AGA Journals blog.

Nivolumab-Associated Colitis Mimicking Ulcerative Colitis

Sept. 1, 2017

Nivolumab was initiated in an 82-year-old man after failing first-line docetaxel for postoperative recurrence of non–small-cell lung cancer.

Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case–Control Study

Sept. 1, 2017

We associated asthma with Crohn’s disease, and with early and late-onset ulcerative colitis.

High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates

Sept. 1, 2017

We associated high dietary intake of specific fatty acids, including myristic acid with an increased risk of flare.

IBD 115: Therapeutic Drug Monitoring in IBD

Aug. 24, 2017

Learn more about Therapeutic Drug Monitoring, based on the AGA Clinical Guideline "Therapeutic Monitoring in Inflammatory Bowel Disease."

A Message for IBD Professionals

Aug. 23, 2017

In this brief video, Dr. Brent Polk shares why the Crohn’s & Colitis Congress™ is the must-attend meeting for IBD education.

Submit Your IBD-Related Abstract for the Crohn’s & Colitis Congress

Aug. 16, 2017

Abstracts will be accepted from Aug. 15 through Oct. 31.

Implementing the Concept of Continuous Clinical Response Into Clinical Practice for Ulcerative Colitis

Aug. 1, 2017

We review the current evidence to assess the feasibility, value, and impact of integrating continuous clinical response as a patient-reported outcome into routine management of UC.

Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study

Aug. 1, 2017

This study compares the effectiveness and safety of infliximab and adalimumab in biologic-naive patients with ulcerative colitis, in a nationwide register-based propensity score–matched cohort study.

Lung-Gut Crosstalk: Airway Disease and IBD

July 6, 2017

Shared inflammatory pathways and genetics may predispose patients with respiratory conditions to developing IBD.